Latest Corporate Governance News

Saluda Medical’s Australian arm has secured ASIC approval to bypass standalone audited financial reports, cutting costs and streamlining compliance.

The ACCC has given the green light for Zurich’s acquisition of ClearView, clearing a major regulatory hurdle. With board and Crescent Capital Partners backing the deal, the transaction edges closer to completion, pending further approvals.

Ausgold Limited has promoted Ben Stockdale from CFO to CEO and appointed Reece Olney as GM Operations, reinforcing its leadership as the Katanning Gold Project approaches a final investment decision.

ASX has appointed Anthony Attia as its next Managing Director and CEO, bringing nearly 30 years of global exchange experience to guide the company through its ongoing transformation.

EVZ Limited's Non-Executive Chairman Graham Burns has sold 5 million shares, reducing his stake but maintaining a significant holding while aiming to improve share liquidity and attract institutional investors.

Synlait Milk announces CEO Richard Wyeth's resignation effective end of June, with Acting CEO Leon Fung appointed immediately to steer through ongoing operational challenges.

Sanford Limited delivered record half-year earnings despite a 5.5% revenue dip, driven by robust salmon and wildcatch segments, while mussel farming faced headwinds. The company cut net debt by NZ$63 million and declared a steady 5.0 cps dividend.

ReadCloud announces CEO Andrew Skelton’s departure after three years of operational overhaul and financial turnaround, appointing CFO Luke Murphy as interim CEO amid strong growth momentum.

Maronan Metals is set for a leadership change as Managing Director Richard Carlton steps down in December 2026, with a CEO search underway to guide the project through feasibility and mine development.

Industrial Minerals Ltd (ASX: IND) is set to acquire the Laverton Gold Portfolio, a drill-ready 205km² package in a prolific WA gold district, backed by a $3 million capital raise and board changes aimed at accelerating exploration.

Atlas Arteria reported a resilient 2025 with 9.3% EBITDA growth and steady toll revenue, while its Board unanimously urged investors to reject IFM’s unsolicited takeover offer, citing undervaluation and onerous conditions.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.